0002147879-26-000001.txt : 20260729 0002147879-26-000001.hdr.sgml : 20260729 20260729112643 ACCESSION NUMBER: 0002147879-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260729 DATE AS OF CHANGE: 20260729 EFFECTIVENESS DATE: 20260729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Research Discovery Innovation Inc. CENTRAL INDEX KEY: 0002147879 ORGANIZATION NAME: EIN: 352904902 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-592454 FILM NUMBER: 261215426 BUSINESS ADDRESS: STREET 1: 875 N MICHIGAN AVENUE STREET 2: SUITE 3950 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-787-8780 MAIL ADDRESS: STREET 1: 875 N MICHIGAN AVENUE STREET 2: SUITE 3950 CITY: CHICAGO STATE: IL ZIP: 60611 D 1 primary_doc.xml X0708 D LIVE 0002147879 Research Discovery Innovation Inc. 875 N MICHIGAN AVENUE SUITE 3950 CHICAGO IL ILLINOIS 60611 312-787-8780 DELAWARE None None Corporation true 2025 Bo von Barnekow-Lofberg 875 N Michigan Avenue Suite 3950 Chicago IL ILLINOIS 60611 Executive Officer Director Stig Lofberg 875 N Michigan Avenue Suite 3950 Chicago IL ILLINOIS 60611 Executive Officer Christina Lofberg-Kaij 875 N Michigan Avenue Suite 3950 Chicago IL ILLINOIS 60611 Executive Officer Pharmaceuticals No Revenues 06b false 2026-07-20 false true false 0 39 039 0 Restricted common stock issued as compensation for advisory services previously rendered: 38,265 shares at $0.001 per share, aggregate value $38.27 (shown rounded to $39). No cash proceeds. true 1 1 0 0 0 The offering generates no cash proceeds; the securities are issued as compensation for advisory services previously rendered. false Research Discovery Innovation Inc. /s/ Bo von Barnekow-Loefberg Bo von Barnekow-Lofberg Vice President 2026-07-29